Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1 - Test2 - elhamkhani - TriplyDB

Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1

Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1

http://www.wikidata.org/entity/Q24676445

about

Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's disease Perispinal etanercept: potential as an Alzheimer therapeutic Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas Exosomes as Novel Regulators of Adult Neurogenic Niches Alzheimer's Disease: Mechanism and Approach to Cell Therapy Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system CD4 T cells in immunity and immunotherapy of Alzheimer's disease Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice Presenilin-1 familial Alzheimer's disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice.miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function Recent developments in the management of dry age-related macular degeneration Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.Vaccine for the mind: Immunity against self at the choroid plexus for erasing biochemical consequences of stressful episodes Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation.Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.Activin A is essential for neurogenesis following neurodegeneration Erratum: Modulation of microglia by Wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model.CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease.T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation.Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS.Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice The role of microglia in human disease: therapeutic tool or target?Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.Microglial recruitment, activation, and proliferation in response to primary demyelination.Cerebral nitric oxide represses choroid plexus NFκB-dependent gateway activity for leukocyte trafficking

P2860

Q21133775-6FAC1964-EB41-45B9-9D6B-394F3DF1FA4D Q22241758-6A8A8242-16CB-44B2-B124-AEB9D0B3B424 Q24810414-D3289065-E163-4E94-BC80-7A08468E040F Q26772836-A425DF8C-9866-4951-9134-A52C1736A098 Q26778149-F44E3A6F-A99F-47E1-827D-13EDDCC3E01E Q26865295-BF929802-3FD9-4A29-BB68-7398904B1F58 Q27024202-6E60062C-3BCE-4345-863A-398E572B8D98 Q27303708-4D0B4E0A-11D6-44E8-B000-72DBCD7E4BDE Q27307172-2F10DB25-F357-46F3-8F2C-766EF396AC0C Q27331488-9C9D025F-D840-41AD-92F0-425B63118626 Q28087564-C95F52DB-64D6-48A1-9BFF-185A64E47C69 Q28088816-8C085FAA-4CCB-49F4-9DCF-F11F05F0BA0C Q28308287-832D2035-6761-42A3-821B-551CF63D18DC Q30054419-90BD62D2-20C9-4993-B87C-F38513F8D21B Q30277388-407C2264-14FF-4D06-9F1A-7ADDFF04D410 Q30448649-D0849700-7529-4538-AA9F-2FE757373CC2 Q30572684-D859CC15-DA01-4142-9E30-85B6BEBC9EE5 Q32178128-C50EBC02-D61A-4A24-B4D6-D0AAE558B615 Q33354106-A8766694-E8D7-4088-91F9-E3062E1B81FE Q33458604-A00F9FA2-27FC-496D-8D86-CEDB24027743 Q33560891-5D06964F-307E-416F-A4F2-08B7205CE18F Q33572146-4D4F7A34-D282-4794-A35F-8702FB74B5D3 Q33593098-BA1E97A5-7148-43C2-9823-C0148BD1AA26 Q33768246-C2CA126D-E3F2-4EA8-B0E1-7C5415D8A77B Q33813553-0BBEC6A2-38BB-4301-AD74-F0237A9B30C5 Q33815568-3608F3F7-FFC4-40DB-9814-527F9CB3D6BE Q33815765-4C2C64EC-CC08-48B2-A45B-1D523960AC7B Q33885228-0A45CFC6-6CC6-4D37-A0F8-7B21A2449AC7 Q33972545-3AEF1A03-E5E5-4281-8DEC-05FF3986CE85 Q33988381-8FFFB402-D6C2-41E9-9D44-C6A621A80D67 Q34003724-92ECD304-1EAC-4871-BFBB-CC04A11E92A8 Q34017180-32453C89-D667-4B56-951A-CFB60C50F0EA Q34038205-E3169EC6-FE24-4895-AC8A-97F5BD5BC23E Q34541218-4ACF9E4E-1530-402A-8C19-200BDA44A256 Q34601956-E202BDA3-4569-411A-A134-81F8F1539445 Q35162073-206AC07A-BAB9-44EF-9C9C-78BC0BE228CD Q35230865-01ECCC6E-2C0C-4994-B4D1-0133C6BCFDB9 Q35599843-C7BEAD70-02B7-4B15-B749-815C78E90082 Q35757235-79C7CE98-631C-49F0-AB6C-7E8C986607AC Q35893142-ED2F5D48-7691-44F3-8698-F36A82603B23

P2860

Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1

http://www.wikidata.org/entity/Q24676445

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@ast

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@en

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@nl

type

label

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@ast

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@en

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@nl

prefLabel

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@ast

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@en

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@nl

P1433

Q24676445-0844B068-E82F-4D3A-8E80-941389D986B5

P1476

Q24676445-947AEAF5-96A7-4C37-955B-F443E8A61B7F

P2093

Q24676445-0DFE4059-A3D6-4E27-82F8-0CE1A57204A0

Q24676445-604DC379-B3C3-4F2E-B834-E90BCB50365B

Q24676445-82BC5F8B-9D35-4DCC-88AE-3D2F20255F61

Q24676445-8CF49A75-7775-4209-8881-A28DB879512A

Q24676445-8F319E8E-B8E9-4F6A-9712-0011DB7BAA27

Q24676445-D4999F86-5333-4015-9516-35244266C00B

Q24676445-F973A92A-EA95-48F0-B4A3-DFE485EC004C

P2860

Q24676445-09294481-53B0-4216-A3C6-ED1C5374B254

Q24676445-0FD40B5D-2A98-4B11-AF77-9796937642DC

Q24676445-19B8FFB8-7489-4D07-A8FA-3857DE7C2489

Q24676445-245148C7-2574-42C6-8297-7E0300D4C75C

Q24676445-2F725781-EEFA-4B9B-B6B5-521F3B0E5921

Q24676445-311162F7-3695-4E7C-A766-8869D052DEFB

Q24676445-43AC565C-90B9-4376-BCA6-6AC3728D2BAD

Q24676445-461988AA-4986-45C2-A3DA-346AEF3F9A1C

Q24676445-4A61E718-744A-4B0A-AFE1-5A7085B44D51

Q24676445-4CFA4D9E-DE63-4E71-8FD3-B95D1A0AA44D

P304

Q24676445-ADDF88B1-9F46-42F2-92EB-5EAFD93EE442

P31

Q24676445-1ACC061A-6FFC-48F7-841A-F4BE0A63A587

P3181

Q24676445-214B83F8-5045-4D54-A00D-04C0E3CB4124

P356

Q24676445-25617528-8C0B-4188-BEAC-CB4C2ABCAF07

P407

Q24676445-FC1B4714-872E-43B4-AF39-2B8D6B397907

P433

Q24676445-FE1CC3AE-3536-49AA-B212-6438FCC02865

P478

Q24676445-70DA3E07-7194-4513-9060-4D6A5FE74B3A

P577

Q24676445-2224B825-29E6-4A15-89ED-B013A5C3556F

P5875

Q24676445-3F762F33-1E16-4C61-A1DA-823ECBFD808A

P698

Q24676445-2A6A099F-1B72-45AE-9D79-341A0BB60B80

P921

Q24676445-1E1C93EA-66A2-4013-ABCF-2498217BABFE

Q24676445-41F01B3E-46DF-448C-9F73-35D4CF469197

Q24676445-6DE4A457-6D7B-4C42-86C2-B2CF1D8AFAE1

P932

Q24676445-C759A43B-9657-4429-9B4E-0C92CCD0E387

P3181

P356

PNAS.0604681103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Glatiramer acetate fights agai ...... g insulin-like growth factor 1

@en

P2093

Eran Ophir

http://www.w3.org/2001/XMLSchema#string

Gennady Landa

http://www.w3.org/2001/XMLSchema#string

Gilad Kunis

http://www.w3.org/2001/XMLSchema#string

Hagit Cohen

http://www.w3.org/2001/XMLSchema#string

Maya Koronyo-Hamaoui

http://www.w3.org/2001/XMLSchema#string

Michal Schwartz

http://www.w3.org/2001/XMLSchema#string

Oleg Butovsky

http://www.w3.org/2001/XMLSchema#string

P2860

Neural consequences of environmental enrichment

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease

Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.

Neurogenesis may relate to some but not all types of hippocampal-dependent learning

Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood

Inflammatory blockade restores adult hippocampal neurogenesis

P304

11784-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4340034

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0604681103

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6921069

http://www.w3.org/2001/XMLSchema#string

P698

16864778

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1544247

http://www.w3.org/2001/XMLSchema#string